Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
45.99
-0.09 (-0.20%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Mirum Pharmaceuticals Revenue
In the year 2024, Mirum Pharmaceuticals had annual revenue of $336.89M with 80.76% growth. Mirum Pharmaceuticals had revenue of $99.41M in the quarter ending December 31, 2024, with 42.93% growth.
Revenue (ttm)
$336.89M
Revenue Growth
+80.76%
P/S Ratio
6.49
Revenue / Employee
$1,046,236
Employees
322
Market Cap
2.25B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
MIRM News
- 3 days ago - LIVMARLI Now Approved in Japan for ALGS and PFIC - Business Wire
- 6 days ago - Mirum Pharmaceuticals: Set Fair For Share Price Momentum - Reversing My Sell Call - Seeking Alpha
- 20 days ago - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Mirum Pharmaceuticals, Inc. (MIRM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update - Business Wire
- 4 weeks ago - Mirum's CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX) - Business Wire
- 5 weeks ago - US FDA approves Mirum Pharma's genetic disorder drug - Reuters
- 5 weeks ago - Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025 - Business Wire